Right to Thrive Medical is a first-of-its-kind clinic pioneering the next generation of healthcare, founded on the principle that patients should have access to the very best care that exists in the world, when they need it.
Where science
and compassion
meet
An American springboard for biomedical innovations—negating the need for patients to travel overseas for the personalized care that they are entitled to at home. Advised by patients. Led by loved ones.
■ ORIGIN
Our work on Right to Thrive began when we felt the despair of watching our loved ones suffer. We resolved to put the frontiers of science in service of the people.
Our team comes from the fields of science, medicine, and law. While our loved ones were being treated for cancer, we felt frustration and desperation alongside them—and their healthcare providers—at the limits of what patients could be offered.
Right to Thrive's single purpose is to deliver the best version of next-generation therapies to Americans here at home, when they need them, so that no patient—and no family—has to travel to another country to receive the care to which they are entitled under law.
Our flagship therapy is peptide-based, n-of-1 cancer vaccine made in collaboration with our design and manufacturing partner, Glyphic Biotechnologies.
Many cancer therapies today carry side effects that meaningfully diminish patients’ quality of life, to the point that patients can no longer recognize themselves. The aspirational standard of “no evidence of disease” does not speak to that lasting toll. Patients deserve options that support a flourishing life rather than diminish it.
Opening Fall 2026 in Stratham, New Hampshire
Right to Thrive is nestled in the lush landscape of the Seacoast region of New Hampshire. 20 minutes away from downtown Portsmouth. 1 hour away from Boston Logan Airport.
■ Mission
What we do
Accelerating
access to care
Our mission is to safely provide individualized therapies, on a timeline measured in weeks, not years.
Personalized path
We coordinate with partners to ensure seamless collection of biological tissues, best-in-class sample processing and data analysis, and bespoke therapy design optimized to enhance efficacy.
Next-generation healthcare
Our clinic offers cash-pay healthcare in the United States with treatments administered from New Hampshire and molecular workups done at home.
■ Team
Founders & leadership
Zach Young
PRESIDENT, RIGHT TO THRIVE HEALTH
Zach oversees Right to Thrive's legal and governance work, corporate operations, and administrative support. He is an accomplished attorney and public servant who turned to this effort after realizing that the medical breakthroughs that might save the life of his mother (and so many others) were not reaching most Americans. He previously attended Stanford Law School as a Knight-Hennessy Scholar and litigated at a major international law firm.
Lola Lozano
EXECUTIVE DIRECTOR, RIGHT TO THRIVE HEALTH
Lola leads Right to Thrive's advisor engagements, manufacturing and sample acquisition oversight, and biotech partnerships. She is a 7th-year MD/PhD candidate at the University of Iowa Medical Scientist Training Program, currently on leave to build Right to Thrive full time. Her graduate work in genetics focused on eye cancers and ocular side-effects of chemotherapy.
■ PARTNERSHIPS
Built with
■ GUIDANCE
Advisory boards
Medical Advisory Board
Practicing physicians who review our care protocols, patient eligibility, and safety monitoring.
Scientific Advisory Board
Researchers in life science and technology who guide which next-generation therapies we bring to patients.
PATIENT ADVISORY BOARD
A standing board of patients, survivors, and caregivers sits at the heart of everything. Their lived experience keeps us honest and ensures the patient remains at the center of our vision—always.
The path to the
new standard of care
By partnering with state and federal governments to make personalized therapy the new standard of care, we aim to increase affordability and accessibility over time.
Start the conversation